Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Muscarinic acetylcholine receptors are transmitters of peripheral and central cholinergic nerves and act specifically on all kinds of choline receptors. Muscarinic acetylcholine receptors play an important role in the treatment of chronic obstructive pulmonary disease, Alzheimer's disease and mental illness. The pharmacological effects of acetylcholine include: slow heart rate, dilation of some blood vessels, weakened contractility of myocardium, decreased blood pressure, and excitement of smooth muscles in gastrointestinal tract, urinary tract and bronchus.
The global Muscarinic Acetylcholine Receptor market report offered by Global Market Monitor provides a detailed analysis of the main driving factors, market trends, business opportunities, threats and challenges of specialty fungicides. This report uses many scientific research methods and collects and organizes important industry-related data. The report provides decisive opinions on market prospects based on leading companies, market size during the forecast period, market share, segmented research, current market trends, activities and major geographic regions. This report provides historical data on market size, compound annual growth value, key company profiles, and analyzes the impact of stakeholders on the Muscarinic Acetylcholine Receptor industry during the forecast period. Through this report, practitioners can have a comprehensive understanding of product knowledge, analyze the current situation of market competition, and devote their precious time to product launches and formulating marketing strategies.
Muscarinic acetylcholine receptors play an important role in the treatment of chronic obstructive pulmonary disease, Alzheimer's disease and mental illness. The rising incidence of these diseases will increase the demand for muscarinic acetylcholine receptors. In addition, increased research and development activities for the therapeutic effects of these receptors will help promote market growth. However, strict government supervision will inhibit this growth. During the forecast period, the muscarinic acetylcholine market will maintain steady growth and reach a considerable compound annual growth rate.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Muscarinic Acetylcholine Receptor market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Muscarinic Acetylcholine Receptor market. Detailed analysis of key players, along with key growth strategies adopted by Muscarinic Acetylcholine Receptor industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Karuna Pharmaceuticals Inc
NeuroHealing Pharmaceuticals Inc
Sumitomo Dainippon Pharma Co Ltd
Heptares Therapeutics Ltd
AstraZeneca Plc
Anavex Life Sciences Corp
By Type:
M1
M4
M5
Others
By End-User:
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer's Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Muscarinic Acetylcholine Receptor Market
-
1.3 Market Segment by Type
-
1.3.1 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of M1 from 2016 to 2027
-
1.3.2 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of M4 from 2016 to 2027
-
1.3.3 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of M5 from 2016 to 2027
-
1.3.4 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2016 to 2027
-
1.4.2 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Psychiatric Disorders from 2016 to 2027
-
1.4.3 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Alzheimer's Disease from 2016 to 2027
-
1.4.4 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2016 to 2027
-
1.4.5 USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Memory Impairment from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Muscarinic Acetylcholine Receptor Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Muscarinic Acetylcholine Receptor by Major Types
-
3.4.1 Market Size and Growth Rate of M1
-
3.4.2 Market Size and Growth Rate of M4
-
3.4.3 Market Size and Growth Rate of M5
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Muscarinic Acetylcholine Receptor Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Muscarinic Acetylcholine Receptor by Major End-Users
-
4.4.1 Market Size and Growth Rate of Muscarinic Acetylcholine Receptor in Attention Deficit Hyperactivity Disorder
-
4.4.2 Market Size and Growth Rate of Muscarinic Acetylcholine Receptor in Psychiatric Disorders
-
4.4.3 Market Size and Growth Rate of Muscarinic Acetylcholine Receptor in Alzheimer's Disease
-
4.4.4 Market Size and Growth Rate of Muscarinic Acetylcholine Receptor in Chronic Obstructive Pulmonary Disease
-
4.4.5 Market Size and Growth Rate of Muscarinic Acetylcholine Receptor in Memory Impairment
5 Market Analysis by Regions
-
5.1 USA Muscarinic Acetylcholine Receptor Production Analysis by Regions
-
5.2 USA Muscarinic Acetylcholine Receptor Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Muscarinic Acetylcholine Receptor Landscape Analysis
-
6.1 West USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major Types
-
6.2 West USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major End-Users
7 South USA Muscarinic Acetylcholine Receptor Landscape Analysis
-
7.1 South USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major Types
-
7.2 South USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major End-Users
8 Middle West USA Muscarinic Acetylcholine Receptor Landscape Analysis
-
8.1 Middle West USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major Types
-
8.2 Middle West USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major End-Users
9 Northeast USA Muscarinic Acetylcholine Receptor Landscape Analysis
-
9.1 Northeast USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major Types
-
9.2 Northeast USA Muscarinic Acetylcholine Receptor Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Karuna Pharmaceuticals Inc
-
10.1.1 Karuna Pharmaceuticals Inc Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 NeuroHealing Pharmaceuticals Inc
-
10.2.1 NeuroHealing Pharmaceuticals Inc Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Sumitomo Dainippon Pharma Co Ltd
-
10.3.1 Sumitomo Dainippon Pharma Co Ltd Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Heptares Therapeutics Ltd
-
10.4.1 Heptares Therapeutics Ltd Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 AstraZeneca Plc
-
10.5.1 AstraZeneca Plc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Anavex Life Sciences Corp
-
10.6.1 Anavex Life Sciences Corp Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of M1 from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of M4 from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of M5 from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Psychiatric Disorders from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Alzheimer's Disease from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease from 2016 to 2027
-
Figure USA Muscarinic Acetylcholine Receptor Market Size and Growth Rate of Memory Impairment from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Muscarinic Acetylcholine Receptor Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Muscarinic Acetylcholine Receptor
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Muscarinic Acetylcholine Receptor by Different Types from 2016 to 2027
-
Table Consumption Share of Muscarinic Acetylcholine Receptor by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of M1
-
Figure Market Size and Growth Rate of M4
-
Figure Market Size and Growth Rate of M5
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Muscarinic Acetylcholine Receptor by Different End-Users from 2016 to 2027
-
Table Consumption Share of Muscarinic Acetylcholine Receptor by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Attention Deficit Hyperactivity Disorder
-
Figure Market Size and Growth Rate of Psychiatric Disorders
-
Figure Market Size and Growth Rate of Alzheimer's Disease
-
Figure Market Size and Growth Rate of Chronic Obstructive Pulmonary Disease
-
Figure Market Size and Growth Rate of Memory Impairment
-
Table USA Muscarinic Acetylcholine Receptor Production by Regions
-
Table USA Muscarinic Acetylcholine Receptor Production Share by Regions
-
Figure USA Muscarinic Acetylcholine Receptor Production Share by Regions in 2016
-
Figure USA Muscarinic Acetylcholine Receptor Production Share by Regions in 2021
-
Figure USA Muscarinic Acetylcholine Receptor Production Share by Regions in 2027
-
Table USA Muscarinic Acetylcholine Receptor Consumption by Regions
-
Table USA Muscarinic Acetylcholine Receptor Consumption Share by Regions
-
Figure USA Muscarinic Acetylcholine Receptor Consumption Share by Regions in 2016
-
Figure USA Muscarinic Acetylcholine Receptor Consumption Share by Regions in 2021
-
Figure USA Muscarinic Acetylcholine Receptor Consumption Share by Regions in 2027
-
Table West USA Muscarinic Acetylcholine Receptor Consumption by Types from 2016 to 2027
-
Table West USA Muscarinic Acetylcholine Receptor Consumption Share by Types from 2016 to 2027
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2016
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2021
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2027
-
Table West USA Muscarinic Acetylcholine Receptor Consumption by End-Users from 2016 to 2027
-
Table West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2016
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2021
-
Figure West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2027
-
Table South USA Muscarinic Acetylcholine Receptor Consumption by Types from 2016 to 2027
-
Table South USA Muscarinic Acetylcholine Receptor Consumption Share by Types from 2016 to 2027
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2016
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2021
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2027
-
Table South USA Muscarinic Acetylcholine Receptor Consumption by End-Users from 2016 to 2027
-
Table South USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2016
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2021
-
Figure South USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2027
-
Table Middle West USA Muscarinic Acetylcholine Receptor Consumption by Types from 2016 to 2027
-
Table Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2016
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2021
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2027
-
Table Middle West USA Muscarinic Acetylcholine Receptor Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2016
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2021
-
Figure Middle West USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2027
-
Table Northeast USA Muscarinic Acetylcholine Receptor Consumption by Types from 2016 to 2027
-
Table Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2016
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2021
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by Types in 2027
-
Table Northeast USA Muscarinic Acetylcholine Receptor Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2016
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2021
-
Figure Northeast USA Muscarinic Acetylcholine Receptor Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Karuna Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Karuna Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Karuna Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Karuna Pharmaceuticals Inc
-
Table Product and Service Introduction of Karuna Pharmaceuticals Inc
-
Table Company Profile and Development Status of NeuroHealing Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NeuroHealing Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of NeuroHealing Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of NeuroHealing Pharmaceuticals Inc
-
Table Product and Service Introduction of NeuroHealing Pharmaceuticals Inc
-
Table Company Profile and Development Status of Sumitomo Dainippon Pharma Co Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sumitomo Dainippon Pharma Co Ltd
-
Figure Sales and Growth Rate Analysis of Sumitomo Dainippon Pharma Co Ltd
-
Figure Revenue and Market Share Analysis of Sumitomo Dainippon Pharma Co Ltd
-
Table Product and Service Introduction of Sumitomo Dainippon Pharma Co Ltd
-
Table Company Profile and Development Status of Heptares Therapeutics Ltd
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Heptares Therapeutics Ltd
-
Figure Sales and Growth Rate Analysis of Heptares Therapeutics Ltd
-
Figure Revenue and Market Share Analysis of Heptares Therapeutics Ltd
-
Table Product and Service Introduction of Heptares Therapeutics Ltd
-
Table Company Profile and Development Status of AstraZeneca Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca Plc
-
Figure Sales and Growth Rate Analysis of AstraZeneca Plc
-
Figure Revenue and Market Share Analysis of AstraZeneca Plc
-
Table Product and Service Introduction of AstraZeneca Plc
-
Table Company Profile and Development Status of Anavex Life Sciences Corp
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Anavex Life Sciences Corp
-
Figure Sales and Growth Rate Analysis of Anavex Life Sciences Corp
-
Figure Revenue and Market Share Analysis of Anavex Life Sciences Corp
-
Table Product and Service Introduction of Anavex Life Sciences Corp
-
